Founder and sole proprietor of Apsara LSC, operating as an independent consultant offering strategic insight and tailored engagements to inform life science investment, business development, product development, P&MA and commercialization strategy.

Supporting gene therapy commercial readiness for the international region. Responsibilities included leading opportunity assessments to support new market expansion strategy, providing operational leadership for new market entry implementation and build out, conducting distributor/partner alliance assessments and managing alliances with business partners in Latin American markets, and providing strategic support in the analysis of regional performance and identification of growth opportunities.

Held roles of increasing responsibility within ICON's Pricing and Market Access team, culminating in leading the EU P&MA practice in London. Responsible for all aspects of organizational and strategic management of the practice, along with sales and delivery of projects primarily focused on asset valuation, P&MA and commercialization strategy. Developed project strategy for over 100 global engagements.

Rapidly advanced from Senior Analyst to Director, earning four promotions in five years. Managed and led projects primarily focused on P&MA strategy for assets in Phase II and III. Developed expertise in qualitative and quantitative pricing methodologies, asset valuation and global market access. Responsible for managing project staffing and capacity for the EU P&MA practice.